Brendan Hannah - CHIEF BUSINESS OFFICER AND COO at Quince Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Officer And Coo
Stock Symbol
QNCX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Brendan Hannah - trading volume in the past year for Quince Therapeutics, Inc.

Holdings reported by Brendan Hannah for Quince Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 297K $187K $0.63 Aug 21, 2024 Direct
Employee Stock Option (right to buy) 47.4K Jun 4, 2024 Direct Common Stock

Transactions reported by Brendan Hannah for Quince Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.